Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Other Non-Current Assets (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Other Non-Current Assets for 6 consecutive years, with $6.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 98.12% to $6.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 million, a 98.12% increase, with the full-year FY2025 number at $6.0 million, up 98.12% from a year prior.
  • Other Non-Current Assets was $6.0 million for Q4 2025 at PROCEPT BioRobotics, up from $3.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.0 million in Q4 2025 to a low of $51000.0 in Q4 2022.
  • A 5-year average of $2.5 million and a median of $3.0 million in 2023 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: crashed 96.57% in 2023, then surged 2219.08% in 2024.
  • PROCEPT BioRobotics' Other Non-Current Assets stood at $777000.0 in 2021, then plummeted by 93.44% to $51000.0 in 2022, then surged by 1701.96% to $919000.0 in 2023, then surged by 230.58% to $3.0 million in 2024, then skyrocketed by 98.12% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Other Non-Current Assets are $6.0 million (Q4 2025), $3.0 million (Q3 2025), and $3.0 million (Q2 2025).